Stage IVA Colon Cancer AJCC v8

10 clinical trials · Condition

Record	Firm	Date
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery (NCT05296681)	Howard S. Hochster, MD	2022-05-03
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events (NCT05038254)	M.D. Anderson Cancer Center	2021-05-12
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases (NCT04752267)	University of Southern California	2021-02-15
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer (NCT04616183)	M.D. Anderson Cancer Center	2020-12-02
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial (NCT04599140)	M.D. Anderson Cancer Center	2020-10-14
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer (NCT04362839)	City of Hope Medical Center	2020-05-27
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer (NCT03992456)	Academic and Community Cancer Research United	2020-04-24
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial (NCT03765736)	Academic and Community Cancer Research United	2020-04-20
Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer (NCT03592641)	National Cancer Institute (NCI)	2019-07-25
M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability (NCT03436563)	M.D. Anderson Cancer Center	2018-03-07

Track Stage IVA Colon Cancer AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.